| Business Summary |
| A biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. |
| General Information |
86 Morris Avenue
Summit, NJ 07901
|
| www.celgene.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 1685 |
| CEO: Dr. Sol J. Barer, Ph.D. |
| Short Interest |
| Current Month (Mil) |
10.19 |
| Previous Month (Mil) |
10.48 |
| Short Interest Ratio (Days) |
1.70 |
| Management Effectiveness |
| Return on Equity |
n.a. |
| Return on Assets |
-34.00 |
| Return on Investments |
-41.00 |
| Profitability |
| Gross Margin |
90.70 |
| EBIT Margin |
-64.50 |
| Profit Margin |
-78.20 |